...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and biological evaluation of a new series of cinnamic acid amide derivatives as potent haemostatic agents containing a 2-aminothiazole substructure
【24h】

Synthesis and biological evaluation of a new series of cinnamic acid amide derivatives as potent haemostatic agents containing a 2-aminothiazole substructure

机译:新系列肉桂酸酰胺衍生物的合成及生物学评价,作为含有2-氨噻唑亚结构的有效的血管科药物

获取原文
获取原文并翻译 | 示例

摘要

Graphical abstract This study demonstrates the use of new compound N5 with potential characteristics for the development of drugs combining coagulant and platelet activities. Display Omitted Abstract Ten new cinnamic acid derivatives containing a 2-aminothiazole substructure were designed and synthesized. This series of compounds exhibited good thermostabilities as demonstrated by thermogravimetric analysis. In coagulation assays (prothrombin time, activated partial thromboplastin time and thrombin time) in vitro , most compounds demonstrated excellent activities to promote blood coagulation. Among the studied series, compounds N1 , N4 , N5 and W5 exhibited a significant coagulation activity. Further studies indicated that compound N5 (IC 50 =1.87μmol/L) displayed the most suitable efficacy of promoting platelet aggregation than the clinically used haemostatic drug etamsylate (IC 50 =46.22μmol/L). Furthermore, the relationship between the functional groups of the compounds and the corresponding blood coagulant activity was explored in this study.
机译:图解摘要本研究表明,使用新的化合物N5具有组合凝结剂和血小板活性的药物发展的潜在特征。显示摘要摘要设计并合成了含有2-氨基噻唑子结构的十种新的肉桂酸衍生物。这一系列化合物表现出良好的热稳定性,通过热重分析证明。在体外凝血测定(凝血酶原时间,活化部分血浆成蛋白时间和血小板时间),大多数化合物都表现出促进血液凝固的优异活性。在研究中,化合物N1,N4,N5和W5表现出显着的凝血活性。进一步的研究表明,化合物N5(IC 50 =1.87μmol/ L)显示出促进血小板聚集的最合适的疗效,而不是临床使用的止血药物素酸酯(IC 50 =46.22μmol/ L)。此外,本研究探讨了化合物的官能团和相应的血液凝结活性之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号